Manufacturing Facilities
We are Committed To Excellence in Quality, Cutting-Edge Technology, & A Drive For Advancing Healthcare.
Uni Medicolabs operates three state-of-the-art production facilities in Dehradun, Uttarakhand, with two of them accredited by EU-GMP. Our advanced infrastructure enables us to meet global quality standards while ensuring efficient and scalable manufacturing.
Currently, UML commercializes its products across Europe, Southeast Asia, the Indian Subcontinent, South America, the MENA region, and Africa.
With a highly experienced team and robust manufacturing capacities across our sites, we have built several long-standing contract manufacturing partnerships. We continue to welcome new collaborations and business opportunities to expand our global footprint.
Penicillin Block
Located in Dehradun, this state-of-the-art facility is a dedicated Penicillin manufacturing plant. Established in 2009, it spans 5,000 sq. meters and operates with a skilled workforce of 150+ professionals. The facility specializes in the production of Penicillin-based formulations, including Co-Amoxiclav & Pip-Taz and serves key emerging markets.
An EU-GMP approved site, the plant upholds the highest standards of quality and compliance, ensuring stringent cGMP controls to prevent cross-contamination. It also houses a sterile dry powder injection line with an annual capacity of 15 million vials, reinforcing its commitment to delivering safe and effective healthcare solutions globally.
Approvals : EU-GMP, FDA Philippines, Drug Administration Vietnam, PPB Kenya, NAFDAC Nigeria, NDA Uganda, NMRA Sri Lanka
General Block 1
This state-of-the-art facility spans 7,000 sq. meters and is supported by a skilled workforce of 200+ professionals. Equipped with advanced manufacturing technology, it is designed to handle commercial batch sizes ranging from 6 kg to 2,000 kg.
The facility houses dedicated production lines for Tablets, Capsules, and Liquids, ensuring flexibility and efficiency in pharmaceutical manufacturing. An EU-GMP approved plant, the site adheres to the highest global quality standards and currently caters to Southeast Asia, the MENA region, and Europe, with a focus on expanding its international presence.
Approvals : EU-GMP, FDA Philippines, Drug Administration Vietnam, PPB Kenya, NAFDAC Nigeria, NDA Uganda, NMRA Sri Lanka
General Block 2
Uni Medicolabs acquired this facility from Unichem Laboratories in 2018. This unit is located in an area covering over 8100 square meters and has a built-up area of 3000 square meters. It can manufacture Tablets, Capsules, Dry Powder Syrups and Dry Powder Sachet.
Approvals : WHO-GMP
5 Billion
Tablets
2 Billion
Capsules
25 Million
DPI Vials
20 Million
Dry Powder Syrup
50 Million
Sachets
25 Million
Oral Liquid Bottles
5 Billion
Tablets
2 Billion
Capsules
25 Million
DPI Vials
20 Billion
Dry Syrup Powder
50 Million
Sachets
25 Million
Oral Liquid